Endo Unit Shutdown Could Strand Incontinence Treatment Praised By FDA Panel
This article was originally published in The Gray Sheet
Endo International plans to shutter its Astora Women's Health business unit – formerly part of American Medical Systems – this month due to ongoing legal concerns tied to the company’s vaginal mesh products. What’s unclear is what this means for the company’s investigational fecal incontinence treatment, which received unanimous support from an FDA advisory panel just days before the shutdown was announced.
Register for our free email digests: